lilly food and drug administration news - Search News

Lilly weight-loss drug copycats dealt blow

Hosted on MSN · 3h

Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.

Detroit News · 6h

Lilly weight-loss drug copycats dealt blow as shortage ends

Eli Lilly and Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, threatening to upend the many knockoffs.

The Washington Post · 21h

Eli Lilly’s weight-loss drug no longer in shortage, FDA says

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.

6hon MSN

Lilly's weight-loss drug removed from FDA's shortage list

The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list ...

7hon MSN

Here’s Why Eli Lilly and Company (LLY) Surged in Q2

PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded ...

4h

Zepbound is no longer in shortage. That could hurt off-brand weight loss drug sellers

The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food ...

19h

Mounjaro and Zepbound no longer in shortage

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...

Daily Reporter4h

Eli Lilly’s weight-loss drugs no longer in shortage, FDA says

Indianapolis-based Eli Lilly’s supply of Mounjaro, which is used to treat Type 2 diabetes, and popular weight-loss drug ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results